Casandra
Casandra Test Code MC90306Version 1 (DRAFT)
Performing Lab
Cannabinoids, Umbilical Cord Tissue
Clinical Use
Order TestUse
Part of the Comprehensive Drug Screen profile for umbilical cord tissue, this assay specifically detects cannabinoids deposited in fetal umbilical cord tissue to assess in‑utero exposure to cannabis during approximately the last trimester of pregnancy.
Special Instructions
Not provided.
Limitations
Reporting limit is determined with each analysis. This assay may not differentiate between delta‑8 and delta‑9 THC or their metabolites. A negative result does not rule out maternal use during pregnancy. Detection depends on maternal usage patterns, drug stability, deposition characteristics in cord tissue, and analytical performance.
Test Details
New York Approved
Methodology
Mass Spectrometry (LC-MS/MS)
Biomarkers
Delta-9 Carboxy THC
AnalyteDelta‑9 Carboxy THC
Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Delta-9 THC
AnalyteDelta‑9 THC
Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
LOINC Codes
Result Codes
- 97584-7 - CarboxyTHC TissCo Ql Scn
- 97586-2 - THC TissCo Ql Scn
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Tissue
Volume
Not provided
Minimum Volume
Not provided
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Not provided |
| Refrigerated | 7 days (preferred) |
| Frozen | 14 days |